x |
No
fee required.
|
o |
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
(1)
|
Title
of each class of securities to which transaction applies:
_____________
|
(2)
|
Aggregate
number of securities to which transaction applies:
_____________
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was determined):
_____________
|
(4)
|
Proposed
maximum aggregate value of transaction:
_____________
|
(5)
|
Total
fee paid: _____________
|
o |
Fee
paid previously with preliminary
materials:
|
o |
Check
box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its
filing.
|
(1)
|
Amount
Previously Paid: _____________
|
(2)
|
Form,
Schedule or Registration Statement No.:
_____________
|
(3)
|
Filing
Party: _____________
|
(4)
|
Date
Filed: _____________
|
1.
|
To
elect directors to hold office until the next Annual Meeting of
Shareholders; and
|
2.
|
To
transact such other business as may properly come before the meeting or
any adjournment thereof.
|
1
|
||
5
|
||
10
|
||
13
|
||
16
|
||
17
|
||
17
|
||
20
|
||
21
|
||
22
|
||
23
|
||
24
|
||
24
|
·
|
is
returned by a broker or other stockholder who does not have authority to
vote;
|
·
|
does
not give authority to a proxy to vote;
or
|
·
|
withholds
authority to vote on one or more
proposals.
|
·
|
the
full set delivery option; or
|
·
|
the
notice only option.
|
·
|
information
regarding the date and time of the Annual Meeting of Shareholders as well
as the items to be considered at the
meeting;
|
·
|
information
regarding the website where the proxy materials are posted;
and
|
·
|
various
means by which a stockholder can request paper or e-mail copies of the
proxy materials.
|
·
|
Send
a written request to the Company’s Corporate Secretary at 16F, National
Development Bank Building, No.2, Gaoxin 1st
RD, Hi-Tech Zone, Xi’an, Shaanxi, China, 710075, if you are a stockholder
of record; or
|
·
|
Notify
your broker, if you hold your common shares in street
name.
|
NAME
|
AGE
|
PRINCIPAL
OCCUPATION
|
||
Guolin
Wang
|
45
|
Professor
of Jiaotong University in Xi’an, China
|
||
Norman
Ko
|
44
|
Partner
of Smith Mandel & Associates, LLP
|
||
Robert
B Fields
|
70
|
Chairman
and Executive Advisor of Actforex, Inc.
|
||
Xiaoqin
Yan
|
31
|
Director
of Shaanxi Tianren Organic Food Co., Ltd.
|
||
Yongke
Xue
|
42
|
Chief
Executive Officer and Chairman of SkyPeople Fruit Juice,
Inc.
|
NAME
|
AGE
|
PRINCIPAL
OCCUPATION
|
||
Yongke
Xue *
|
42
|
Chief
Executive Officer and Chairman of SkyPeople Fruit Juice,
Inc.
|
||
Spring
Liu
|
36
|
Chief
Financial Officer and Corporate
Secretary
|
1.
|
Employment of executive
officers. Any
employment by the Company of an executive officer of the Company
if:
|
|||||
a.
|
the
related compensation is required to be reported in the Company’s proxy
statement under Item 402 of the SEC’s compensation disclosure
requirements (generally applicable to “named executive officers”);
or
|
|||||
b.
|
the
executive officer is not an immediate family member of another executive
officer or director of the Company, the related compensation would be
reported in the Company’s proxy statement under Item 402 of the SEC’s
compensation disclosure requirements if the executive officer was a “named
executive officer”, and the Company’s Compensation Committee approved (or
recommended that the Board approve) such compensation.
|
|||||
2.
|
Director
compensation. Any
compensation paid to a director if the compensation is required to be
reported in the Company’s proxy statement under Item 402 of the SEC’s
compensation disclosure requirements.
|
|||||
3.
|
Certain transactions with
other companies. Any
transaction with another company at which a Related Person’s only
relationship is as an employee (other than an executive officer), director
or beneficial owner of less than 10% of that company’s shares, if the
aggregate amount involved does not exceed 2 percent of that company’s
total annual revenues.
|
|||||
4.
|
Certain Company charitable
contributions. Any
charitable contribution, grant or endowment by the Company to a charitable
organization, foundation or university at which a Related Person’s only
relationship is as an employee (other than an executive officer) or a
director, if the aggregate amount involved does not exceed the lesser of
$50,000 or 2 percent of the charitable organization’s total annual
receipts.
|
5.
|
Transactions where all
shareholders receive proportional benefits. Any
transaction where the Related Person’s interest arises solely from the
ownership of the Company’s Common Stock and all holders of the Company’s
Common Stock received the same benefit on a pro rata basis (e.g.
dividends).
|
|
6.
|
Transactions involving
competitive bids. Any
transaction involving a Related Party where the rates or charges involved
are determined by competitive bids.
|
|
7.
|
Regulated
transactions. Any
transaction with a Related Party involving the rendering of services as a
common or contract carrier, or public utility, at rates or charges fixed
in conformity with law or governmental authority.
|
|
8.
|
Certain banking-related
services. Any
transaction with a Related Party involving services as a bank depositary
of funds, transfer agent, registrar, trustee under a trust indenture, or
similar services.
|
Title
of Class
|
Name
and Address of
Beneficial
Owners (1)
(2)
|
Amount
and Nature of
Beneficial
Ownership
|
Percent
of Class
|
|||||||
Common
Stock
|
Hongke
Xue (3)
|
17,604,938 | 79.1 | % | ||||||
Common
Stock
|
Lin
Bai (4)
|
2,200,617 | 9.9 | % | ||||||
Common
Stock
|
Sixiao
An (5)
|
2,200,617 | 9.9 | % | ||||||
Common
Stock
|
Yongke
Xue
|
— | — | |||||||
Common
Stock
|
Spring
Liu
|
— | — | |||||||
Common
Stock
|
Xiaoqin
Yan
|
— | — | |||||||
Common
Stock
|
Guolin
Wang
|
— | — | |||||||
Common
Stock
|
Robert
B. Fields
|
— | — | |||||||
Common
Stock
|
Norman
Ko
|
— | — | |||||||
Common
Stock
|
Barron
Partners LP
730
Fifth Avenue, 9th Floor
New
York, New York 10019
|
10,159,265 | (6 | ) | 31.3 | % | ||||
Common
Stock
|
Joseph
Emas (7)
1224
Washington Avenue
Miami
Beach, Florida 33139
|
5,113 | * | |||||||
Common
Stock
|
All
officers and directors as a group
(six
persons)
|
— | — |
(1)
|
Pursuant to Rule 13d-3 under the
Exchange Act, a person has beneficial ownership of any securities as to
which such person, directly or indirectly, through any contract,
arrangement, undertaking, relationship or otherwise has or shares voting
power and/or investment power or as to which such person has the right to
acquire such voting and/or investment power within 60
days.
|
(2)
|
Unless otherwise stated, each
beneficial owner has sole power to vote and dispose of the shares and the
address of such person is c/o the Company, at 16F,
National Development Bank Tower, Gaoxin 2nd Road, Hi-Tech
Industrial Zone, Xi’an, Shaanxi Province, PRC
710075.
|
(3)
|
Consists
of 17,604,938 shares owned of record by Fancylight Limited, a British
Virgin Islands company (“Fancylight”). Fancylight and Hongke Xue have
entered into a Call Option Agreement pursuant to which Mr. Xue has the
right to acquire all of such shares. Fancylight and Mr. Xue have also
entered a Voting Trust Agreement, dated as of February 25, 2008, under
which Mr. Xue has been appointed as voting trustee under a voting trust
created with respect to all of such shares. Therefore, Mr. Xue may be
deemed to be the sole beneficial owner of such
shares.
|
(4)
|
Consists
of 2,200,617 shares owned by China Shaanxi Tianren Organic Food Holding
Company Limited, as attorney-in-fact for certain persons. China Shaanxi
Tianren Organic Food Holding Company Limited (“Organic”) is a British
Virgin Islands company. Organic and Lin Bai have entered into a Voting
Trust and Escrow Agreement dated as of February 25, 2008 pursuant to which
Lin Bai has been appointed as voting trustee under a voting trust created
with respect to all of such shares. Therefore, Lin Bai may be deemed to be
the sole beneficial owner of such
shares.
|
(5)
|
Consists of 2,200,617 shares
owned by Winsun Limited, as attorney-in-fact for certain persons. Winsun
Limited (“Winsun”) is a British Virgin Islands company. Winsun and Sixiao
An have entered into a Voting Trust and Escrow Agreement dated as of
February 25, 2008 pursuant to which Sixiao An has been appointed as voting
trustee under a voting trust created with respect to all of such shares.
Therefore, Sixiao An may be deemed to be the sole beneficial owner of such
shares.
|
(6)
|
Consists of (a) 6,794,118 shares
of Common Stock issuable upon exercise of warrants and (b) an aggregate of
3,365,147 shares of Common Stock issuable upon conversion of Series B
Stock. The warrants held by Barron Partners LP became exercisable upon the
effectiveness of a 1-for-328.72898 reverse stock split of the Company’s
Common Stock on May 23, 2008, and the number of shares for which the
warrants are exercisable and the exercise price of the warrants were not
adjusted for such reverse stock
split.
|
(7)
|
Consists of 5,000 shares of
Common Stock issuable upon exercise of warrants which were issued on May
23, 2008. Joseph I. Emas is a principal of Joseph I. Emas Law Offices,
which is the record owner of 113 shares of Common Stock. He was a director
of the Company from February 22, 2008 until he resigned on April 7,
2008.
|
Name
and
Principal
Position
|
Year
Ended
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
|
Option
Awards
|
Non-Equity
Incentive Plan Compensation ($)
|
Non-Qualified
Deferred Compensation Earnings ($)
|
All
Other Compensation ($)
|
Total
($)
|
|||||||||||
Yongke
Xue
|
12/31/2007
|
$
|
0.00
|
—
|
—
|
—
|
—
|
—
|
—
|
$
|
0.00
|
|||||||||
CEO
|
12/31/2008
|
$
|
0.00
|
—
|
—
|
—
|
—
|
—
|
—
|
$
|
0.00
|
|||||||||
Spring
Liu (1)
|
12/31/2007
|
$
|
0.00
|
—
|
—
|
—
|
—
|
—
|
—
|
$
|
0.00
|
|||||||||
CFO
|
12/31/2007
|
$
|
58,192.26
|
—
|
—
|
—
|
—
|
—
|
—
|
$
|
58,192.26
|
Name
|
Fees
Earned or Paid in Cash ($)(1)
|
Stock
Awards ($)
|
Option
Awards ($)
|
Non-equity
Incentive Plan Compensation ($)
|
Change
in Pension Value and Nonqualified Deferred Compensation Earnings
($)
|
All
Other Compensation ($)
|
Total
($)
|
|||||||||||||||||||||
Yongke
Xue
|
$ | — | — | — | — | — | — | $ | — | |||||||||||||||||||
Xiaoqin
Yan
|
$ | — | — | — | — | — | — | $ | — | |||||||||||||||||||
Guolin
Wang(2)
|
$ | — | — | — | — | — | — | $ | — | |||||||||||||||||||
Norman
Ko
|
$ | 25,000 | — | — | — | — | — | $ | 25,000 | |||||||||||||||||||
Robert
B. Fields
|
$ | 25,000 | — | — | — | — | — | $ | 25,000 |
(1)
|
Cash
compensation for Board and committee meeting attendance and service as a
committee chairman.
|
|
(2)
|
Mr.
Wang is a PRC resident and the Company’s policy is not to provide cash
compensation for director services to non-employee directors who are PRC
residents. The Company believes that this is a common practice for
companies with their primary operations in the
PRC.
|
·
|
attract,
motivate and retain executives who drive the Company’s success and
industry leadership;
|
·
|
provide
each executive, from Vice-President to Chief Executive Officer, with a
base salary based on the market value of that role, and the individual’s
demonstrated ability to perform that
role.
|
COMPENSATION
COMMITTEE
Guolin
Wang
Norman
Ko
Yongke
Xue
Xiaoqing
Yan
|
·
|
a
detailed resume of the recommended
candidate;
|
·
|
an
explanation of the reasons why the stockholder believes the recommended
candidate is qualified for service on the Corporation’s
Board;
|
·
|
such
other information that would be required by the rules of the SEC to be
included in a proxy statement;
|
·
|
the
written consent of the recommended
candidate;
|
·
|
a
description of any arrangements or undertakings between the stockholder
and the recommended candidate regarding the nomination;
and
|
·
|
proof
of the recommending stockholder’s stock holdings in the
Corporation.
|
2008
|
2007
|
|||||||
Audit
Fees
|
$ | 99,000 | $ | 102,121 | ||||
All
Other Fees
|
24,000 | -- | ||||||
$ | 123,000 | $ | 102,121 |
|
o FOR
all nominees
o WITHHOLD
AUTHORITY FOR ALL NOMINEES
o
FOR ALL EXCEPT (See instructions
below)
|
Dated:
|
|
|
|
||
Signature
|
||
Signature,
if held jointly
|
||
Title
(if applicable)
|
||
Please
date, sign exactly as your name appears on this Proxy and promptly return
in the enclosed envelope. In the case of joint ownership, each
joint owner must sign. When signing as guardian, executor,
administrator, attorney, trustee, custodian, or in any other similar
capacity, please give full title. If a corporation, sign in
full corporate name by president or other authorized officer, giving
title, and affix corporate seal. If a partnership, sign in
partnership name by authorized
person.
|
I.
|
Purpose
|
II.
|
Membership
|
III.
|
Duties
and Responsibilities
|
1.
|
Consider
and authorize the compensation philosophy for the Company's
personnel.
|
2.
|
Monitor
and evaluate matters relating to the compensation and benefits structure
of the Company as the Committee deems
appropriate.
|
3.
|
Review
and approve corporate goals and objectives relevant to the Chief Executive
Officer and other executive officers’ compensation, evaluate the Chief
Executive Officer and other executive officers performance in light of
those goals and objectives and, either as a committee or together with
other independent Directors (as directed by the Board of Directors),
determine and approve the Chief Executive Officer and other executive
officers’ compensation based on this
evaluation.
|
4.
|
At
least once each calendar year, review and approve all compensation for all
the non-employee Directors and other employees of the Company or its
subsidiaries with a base salary greater than or equal to $100,000. No
member of the Committee will act to fix his or her own compensation except
for uniform compensation to Directors for their services as a
Director.
|
5.
|
With
the input of the Chief Executive Officer, at least once each calendar
year, review the performance of principal senior
executives.
|
6.
|
Review
the terms of the Company’s incentive compensation plans, equity-based
plans, retirement plans, deferred compensation plans and welfare benefit
plans. The Committee shall administer such plans, including determining
any incentive or equity-based awards to be granted to members of senior
management under any such plan.
|
7.
|
Review
and approve executive officer and Director indemnification and insurance
matters.
|
8.
|
Review
and discuss the Compensation Discussion and Analysis section proposed for
inclusion in the Company’s Annual Report on Form 10-K and annual proxy
statement with management and recommend to the Board whether such section
should be so included. In that connection, the Committee shall also review
the related tabular and other disclosures about Director and executive
compensation proposed by management for inclusion in such Annual Report
and proxy statement.
|
9.
|
Prepare
and approve the Committee report to be included as part of the Company’s
annual proxy statement.
|
10.
|
Evaluate
its own performance on an annual basis and report on such performance to
the Board.
|
11.
|
Review
and reassess this Charter at least once each fiscal year and submit any
recommended changes to the Board for its
consideration.
|
12.
|
Have
such other powers and functions as may be assigned to it by the Board from
time to time.
|
I.
|
Meetings
|
II.
|
Committee
Resources and Advisors
|
I.
|
Purpose
and Scope
|
·
|
assisting
the Board of Directors in fulfilling its
responsibilities by reviewing: (i) the financial reports provided by
the Company to
the Securities and
Exchange Commission ("SEC"), the
Company’s stockholders or to the general public, and (ii) the
Company’s
internal financial and accounting controls;
|
·
|
recommending, establishing
and monitoring procedures designed to
improve
the quality and reliability of
the disclosure of the Company's financial condition
and results of operations;
|
·
|
overseeing the
appointment, compensation, and evaluation of the qualifications and
independence of the Company’s independent
auditors;
|
·
|
overseeing
the Company’s compliance with legal and regulatory
requirements;
|
·
|
overseeing
the adequacy of the Company’s internal controls and procedures to promote
compliance with accounting standards and applicable laws and
regulations;
|
·
|
engaging advisors
as necessary; and
|
·
|
determining
the funding from the Company that is necessary or appropriate to carry out
the Committee's duties.
|
II.
|
Membership
|
III.
|
Duties
and Responsibilities
|
1.
|
The
Committee shall review and assess the adequacy of this Charter at least
annually.
|
2.
|
The
Committee shall review and discuss with representatives of management and
representatives of the independent accounting firm the Company's quarterly
and annual financial statements prior to any filing with the SEC or any
release to the public or investors.
|
3.
|
The
Committee shall recommend to the Board, if appropriate, that the Company’s
annual audited financial statements be included in the Company’s annual
report on Form 10-K for filing with the
SEC.
|
4.
|
The
Committee shall be directly responsible for the appointment, compensation,
retention and oversight of the work of the Company’s independent
auditors. The authority of the Committee shall include ultimate
authority to approve all audit engagement fees and terms. The
Committee shall have the ultimate authority and responsibility to
appoint, evaluate and, when warranted, replace such independent accounting
firm (or to recommend such replacement for shareholder approval in any
proxy statement).
|
5.
|
The
Committee shall resolve any disagreements between management and the
independent auditors as to financial reporting
matters.
|
6.
|
The
independent auditors shall report directly to the Committee on matters
pertaining to the work performed during its engagement and on matters
required by applicable Regulatory Body rules and
regulations.
|
7.
|
The
Committee shall take such action as it reasonably believes is necessary to
confirm and assure the independence of the independent
accountant. In that regard, the Audit Committee is responsible
for actively engaging in dialogue with the independent accountant with
respect to any disclosed relationships or services that may impact on the
objectivity and independence of the independent accountant and for taking,
or recommending that the Board of Directors take, appropriate action
to oversee the independence of the independent
accountant.
|
8.
|
The
Committee shall review the annual audit plan of the outside auditors and
evaluate their performance.
|
9.
|
The
Committee shall evaluate the performance of the independent auditors and
consider the discharge of the independent auditors when circumstances
warrant. The independent auditors shall be ultimately accountable to the
Committee.
|
10.
|
The
Committee shall oversee the rotation of the lead (or coordinating) audit
partner having primary responsibility for the audit, and the audit partner
responsible for reviewing the audit at least once every five years, and
oversee the rotation of other audit partners in accordance with applicable
rules and regulations.
|
11.
|
The
Committee shall approve in advance all audit and non-audit services to be
performed by the independent
auditors.
|
12.
|
The
Committee shall have the authority to oversee and determine the
compensation of any independent auditors engaged by the Company and shall
notify the Company of any anticipated funding needs of the
Committee.
|
13.
|
The
Committee shall consider and review with the Company’s independent
auditors and management any significant findings and any review or audit
problems or difficulties encountered in the course of the review or audit
work during the quarterly review and year-end audit, and management’s
responses to them.
|
14.
|
The
Committee shall annually review the qualifications, performance and
independence of the independent auditors and the senior members of the
independents auditors’ audit engagement
team.
|
15.
|
The
Committee shall discuss with management and the independent auditors any
accounting adjustments that were noted or proposed by the independent
auditors, but not adopted or
reflected.
|
16.
|
The
Committee shall annually obtain and review a report by the independent
auditors describing (i) the independent auditors’ internal quality-control
procedures; and (ii) any material issues raised by the most recent
internal quality-control review or peer review of the audit firm, or by
any inquiry or investigation by governmental or professional authorities,
within the preceding five years, respecting one or more independent audits
carried out by the audit firm, and any steps taken to deal with such
issues.
|
17.
|
The
Committee shall review the responsibilities, budget and staffing of any
internal auditors.
|
18.
|
The
Committee shall review the reports of the Chief Executive Officer and
Chief Financial Officer (in connection with their required certifications
for the Company’s filings with the SEC) regarding any significant
deficiencies or material weaknesses in the design or operation of internal
controls, and any fraud that involves management or other employees who
have a significant role in the Company’s internal
controls.
|
19.
|
The
Committee shall consult with the Company’s independent auditors concerning
the completeness and accuracy of the Company’s financial
statements.
|
20.
|
The
Committee shall review disclosures made to the Committee by the Company’s
Chief Executive Officer and Chief Financial Officer in connection with
their certifications of the Company's Annual Reports on Form 10-K and
Quarterly Reports on Form 10-Q, including disclosures concerning (a)
evaluations of the design and operation of the Company’s internal control
over financial reporting, (b) significant deficiencies and material
weaknesses in the design and operation of the Company's internal control
over financial reporting which are reasonably likely
to adversely affect the Company's ability to
record, process, summarize,
and report financial information, and
(c) any fraud, whether or not material, that
involves management or other employees who have a significant
role in the Company's internal controls. The Committee shall
direct the actions to be taken and/or make recommendations to the Board of
Directors of actions to be taken to the extent such disclosures indicate
the finding of any significant deficiencies in internal controls or
fraud.
|
21.
|
The
Committee shall review changes to the Company’s accounting principles as
recommended by the outside auditors or
management.
|
22.
|
The
Committee shall review periodically with the Company’s management, general
counsel and outside auditors, legal and regulatory matters and accounting
initiatives that could have a significant effect on the Company’s
financial statements.
|
23.
|
The
Committee shall prepare, in accordance with the rules of the SEC as
modified or supplemented from time to time, a written report of the
Committee to be included in the Company's annual proxy statement for each
annual meeting of stockholders.
|
24.
|
To
the extent required by any Regulatory Body, the Committee shall instruct
the Company's management to disclose in its annual proxy statement for
each annual meeting of stockholders, Annual Report on Form 10-K and
Quarterly Report on Form 10-Q, the approval by the Committee of any
non-audit services performed by the independent accounting firm, and
review the substance of any such disclosure and the considerations
relating to the compatibility of such services with
maintaining the independence of the accounting
firm.
|
25.
|
The
Committee is responsible for reviewing existing policies concerning
related party transactions and conflicts of interest between Board members
or senior management, on the one hand, and the Company, on the other hand,
and recommend any changes to such policies. Attached hereto as Schedule A
is the Company’s Statement of Policies and Procedures with Respect to
Related Party Transactions which was approved by the Board of Directors of
the Company on September 30, 2008 and is currently in
effect
|
26.
|
The
Committee must perform an annual
self-evaluation.
|
27.
|
The
Committee shall investigate any other matter brought to its attention
within the scope of its duties which it deems appropriate for
investigation.
|